全文获取类型
收费全文 | 905篇 |
免费 | 75篇 |
国内免费 | 45篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 85篇 |
妇产科学 | 9篇 |
基础医学 | 83篇 |
口腔科学 | 19篇 |
临床医学 | 134篇 |
内科学 | 200篇 |
皮肤病学 | 20篇 |
神经病学 | 77篇 |
特种医学 | 134篇 |
外科学 | 74篇 |
综合类 | 20篇 |
预防医学 | 40篇 |
眼科学 | 11篇 |
药学 | 71篇 |
中国医学 | 3篇 |
肿瘤学 | 26篇 |
出版年
2021年 | 13篇 |
2020年 | 9篇 |
2019年 | 13篇 |
2018年 | 19篇 |
2017年 | 15篇 |
2016年 | 11篇 |
2015年 | 21篇 |
2014年 | 23篇 |
2013年 | 35篇 |
2012年 | 16篇 |
2011年 | 28篇 |
2010年 | 32篇 |
2009年 | 36篇 |
2008年 | 27篇 |
2007年 | 48篇 |
2006年 | 23篇 |
2005年 | 24篇 |
2004年 | 17篇 |
2003年 | 20篇 |
2002年 | 19篇 |
2001年 | 13篇 |
2000年 | 19篇 |
1999年 | 20篇 |
1998年 | 49篇 |
1997年 | 39篇 |
1996年 | 38篇 |
1995年 | 26篇 |
1994年 | 18篇 |
1993年 | 23篇 |
1992年 | 16篇 |
1991年 | 20篇 |
1990年 | 26篇 |
1989年 | 36篇 |
1988年 | 46篇 |
1987年 | 36篇 |
1986年 | 29篇 |
1985年 | 21篇 |
1984年 | 9篇 |
1983年 | 14篇 |
1982年 | 10篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1979年 | 3篇 |
1978年 | 8篇 |
1977年 | 11篇 |
1976年 | 8篇 |
1975年 | 6篇 |
1973年 | 5篇 |
1972年 | 4篇 |
1969年 | 4篇 |
排序方式: 共有1025条查询结果,搜索用时 31 毫秒
31.
32.
Brittney Murray Rohan Wagle Nuria Amat‐Alarcon Alisha Wilkens Paul Stephens Elaine H. Zackai Elizabeth Goldmuntz Hugh Calkins Matthew A. Deardorff Daniel P. Judge M.D. 《American journal of medical genetics. Part A》2013,161(2):371-376
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a familial form of cardiomyopathy typically caused by mutations in genes that encode an element of the cardiac desmosome. Branchio‐oculo‐facial syndrome (BOFS) is a craniofacial disorder caused by TFAP2A mutations. In a family segregating ARVD/C, some members also had features of BOFS. Genetic testing for ARVD/C identified a mutation in PKP2, encoding plakophilin‐2, a component of the cardiac desmosome. Evaluation of dysmorphology by chromosome microarray (CMA) identified a 4.4 Mb deletion at chromosome 6p24 that included both TFAP2A and DSP, encoding desmoplakin, an additional component of the cardiac desmosome implicated in ARVD/C. A family member with both the 6p24 deletion and PKP2 mutation had more severe cardiac dysfunction. These findings suggest that this contiguous gene deletion contributes to both ARVD/C and BOFS, and that DSP haploinsufficiency may contribute to cardiomyopathy. This family provides a clinical example that underscores the need for careful evaluation in clinical scenarios where genetic heterogeneity is known to exist. Finally, it suggests that individuals with unexplained cardiomyopathy and dysmorphic facial features may benefit from CMA analysis. © 2013 Wiley Periodicals, Inc. 相似文献
33.
34.
35.
In this case, a male patient presented with a clinically and radiographieally unstable slipped capital femoral epiphysis (SCFE) as well as slipped calcaneal epiphysis years. Subsequent thorough at the age of 23 work-up revealed that he had some features of rickets and labo- ratory test demonstrated he had hypophos- phatemia (2.3mg/dl), normocalcemia, normal vi- tamin D metabolite levels, and secondary hy- perparathyroidism. 相似文献
36.
Comparison of the subacute toxicity and efficacy of 3-hydroxypyridin-4- one iron chelators in overloaded and nonoverloaded mice 总被引:3,自引:1,他引:3
Five orally effective iron chelators of the 3-hydroxypyridin-4-one series have been administered intraperitoneally to iron-overloaded and nonoverloaded male mice at a dose of 200 mg/kg/24 h for a total of 60 days to investigate the effect on iron loading and toxicity. There was a significant reduction in hepatic iron at the end of the study in the iron-overloaded mice with all compounds studied using chemical iron quantitation (P less than .001) and with Perls' stain (P less than .01). Liver iron removal with the hydroxypyridinones ranged from 37% with CP20 to 63% with CP51, compared with 46% removal for desferrioxamine (DFO). There was no significant reduction in splenic or cardiac iron with any chelator. There were no deaths in iron-overloaded animals receiving any of the hydroxypyridin-4-ones, but significantly more deaths in the nonoverloaded groups as a whole (P less than .03). No weight loss was observed with any chelator. Significant reductions in hemoglobin and white cell count were observed with CP20(L1). No histologic abnormalities of kidney, spleen, bone marrow, or stifle joints were observed. Intracytoplasmic inclusion bodies were observed in the centrilobular hepatocytes of animals administered each of the hydroxypyridin-4-ones, while the DFO-treated and control groups showed no such changes. 相似文献
37.
Detection of anti-HTLV-I Tax antibodies in HTLV-I enzyme-linked immunosorbent assay-negative individuals 总被引:10,自引:0,他引:10
Ehrlich GD; Glaser JB; Abbott MA; Slamon DJ; Keith D; Sliwkowski M; Brandis J; Keitelman E; Teramoto Y; Papsidero L 《Blood》1989,74(3):1066-1072
The HTLV-I tax gene protein (Tax) is not packaged within the mature viral particle from which the proteins for the commercially available enzyme-linked immunosorbent assay (ELISA) are derived. Screening of 162 individuals within a cohort of white intravenous (IV) drug abusers, previously identified as having an increased incidence of HTLV-I infection, demonstrated that seven of them had antibodies to the HTLV-I Tax protein but tested negative in HTLV-I ELISAs and Western blots prepared from purified virion proteins. Three out of 35 individuals in other behaviorally defined high-risk groups also displayed this limited pattern of reactivity to HTLV-I proteins. The presence of the anti-HTLV- I p40/Tax antibodies was determined by radioimmunoprecipitation assay (RIPA), which also revealed low levels of anti-env reactivity. The specificity of the anti-p40 reactivity was confirmed on specific Tax ELISAs and Western blots prepared from recombinantly produced Tax. In vitro gene amplification by the polymerase chain reaction (PCR) was used to establish the presence of sequences homologous to HTLV-I proviral DNA in four/four of these HTLV-I ELISA negative, Tax ELISA/Tax western blot/RIPA positive individuals. These data suggest that the true incidence of HTLV-I infection within high-risk cohorts is greater than previously reported. 相似文献
38.
Samuel Saire-Saire Eduardo C. M. Barbosa Daniel Garcia Leandro H. Andrade Sergi Garcia-Segura Pedro H. C. Camargo Hugo Alarcon 《RSC advances》2019,9(38):22116
Gold nanoparticles (Au NPs) have been widely employed in catalysis. Here, we report on the synthesis and catalytic evaluation of a hybrid material composed of Au NPs deposited at the surface of magnetic cobalt ferrite (CoFe2O4). Our reported approach enabled the synthesis of well-defined Au/CoFe2O4 NPs. The Au NPs were uniformly deposited at the surface of the support, displayed spherical shape, and were monodisperse in size. Their catalytic performance was investigated towards the reduction of 4-nitrophenol and the selective oxidation of dimethylphenylsilane to dimethylphenylsilanol. The material was active towards both transformations. In addition, the LSPR excitation in Au NPs could be employed to enhance the catalytic performance, which was demonstrated in the 4-nitrophenol reduction. Finally, the magnetic support allowed for the easy recovery and reuse of the Au/CoFe2O4 NPs. In this case, our data showed that no significant loss of performance took place even after 10 reaction cycles in the oxidation of dimethylphenylsilane to dimethylphenylsilanol. Overall, our results indicate that Au/CoFe2O4 are interesting systems for catalytic applications merging high performances, recovery and re-use, and enhancement of activities under solar light illumination.We present a cleaner chemical synthesis process of a magnetic recoverable Au/CoFe2O4 hybrid nanocomposite catalyst that has remarkable activity in catalytic reduction and oxidation, improved by surface plasmon resonance. 相似文献
39.
Bharmal Sakina Huseni Cho Jaelim Alarcon Ramos Gisselle Charlott Ko Juyeon Stuart Charlotte Elizabeth Modesto Andre Eto Singh Ruma Girish Petrov Maxim Sergey 《Journal of gastroenterology》2020,55(8):775-788
Journal of Gastroenterology - New-onset diabetes is the most common sequela of acute pancreatitis (AP). Yet, prospective changes in glycaemia over time have never been investigated comprehensively... 相似文献
40.
EG Burden RW Walker DJ Ferguson AMF Goubran JR Howell JB John F Khan JS McGrath JP Evans 《Annals of the Royal College of Surgeons of England》2021,103(3):173
IntroductionWith the emergence of the COVID-19 pandemic, all elective surgery was temporarily suspended in the UK, allowing for diversion of resource to manage the anticipated surge of critically unwell patients. Continuing to deliver time-critical surgical care is important to avoid excess morbidity and mortality from pathologies unrelated to COVID-19. We describe the implementation and short-term surgical outcomes from a system to deliver time-critical elective surgical care to patients during the COVID-19 pandemic.Materials and methodsA protocol for the prioritisation and safe delivery of time-critical surgery at a COVID-19 ‘clean’ site was implemented at the Nuffield Health Exeter Hospital, an independent sector hospital in the southwest of England. Outcomes to 30 days postoperatively were recorded, including unplanned admissions after daycase surgery, readmissions and complications, as well as the incidence of perioperative COVID-19 infection in patients and staff.ResultsA total of 128 surgical procedures were performed during a 31-day period by a range of specialties including breast, plastics, urology, gynaecology, vascular and cardiology. There was one unplanned admission and and two readmissions. Six complications were identified, and all were Clavien-Dindo grade 1 or 2. All 128 patients had preoperative COVID-19 swabs, one of which was positive and the patient had their surgery delayed. Ten patients were tested for COVID-19 postoperatively, with none testing positive.ConclusionThis study has demonstrated the implementation of a safe system for delivery of time-critical elective surgical care at a COVID-19 clean site. Other healthcare providers may benefit from implementation of similar methodology as hospitals plan to restart elective surgery. 相似文献